ABVC BioPharma Inc. Common Stock (ABVC)
Stock · NASDAQ · Health Care
$0.918as of 10/16/2026
Price chart
Active signals
ABVC Signal Track Record
How signals performed across all stocks →What ABVC's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 31 | -4.6% | 32% | September 15, 2026 |
| Bollinger Band Breakout | 19 | -8.5% | 32% | September 8, 2026 |
| Bollinger Band Breakdown | 17 | -3.5% | 47% | March 18, 2026 |
| 200-Day Moving Average TouchActive now | 3 | -8.8% | 33% | December 23, 2025 |
| Any 20-session window (baseline) | -5.2% | 39% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ABVC
ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for a…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 16
- Website
- abvcpharma.com/
Fundamentals
- 1-day range
- $0.9$0.945
- Market cap
- $27.09M
- P/E (trailing)
- —
- P/E (forward)
- -2.09
- EPS (trailing)
- $-0.32
- Dividend yield
- —
- Beta
- 0.50
- Avg. volume
- 108.1K
- Dividend pay date
- May 8, 2019
How ABVC BioPharma Inc. Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Apr 15, 2025 · via SEC EDGAR / Finnhub
ABVC BioPharma Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- ABVCABVC BioPharma Inc. Common Stock$0.918▼ 1.61%Market cap $27.09MP/E —$0.7069$3.07
- KYNBKyntra Bio Inc. Common Stock$4.85▼ 9.51%Market cap $28.26MP/E 0.12$5.34$11.65
- RMTIRockwell Medical Inc. Common Stock$7.43▼ 6.89%Market cap $28.26MP/E —$4.89$12.9
- GRCEGrace Therapeutics Inc. Common Stock$1.89▼ 3.08%Market cap $28.44MP/E —$1.79$5.18
- MIRAMIRA Pharmaceuticals Inc. Common Stock$0.632▼ 3.95%Market cap $28.50MP/E —$0.6$2.45
- AYTUAytu BioPharma Inc. Common Stock$2.04▲ 1.49%Market cap $25.01MP/E —$1.8$3.07
- ACTUActuate Therapeutics Inc. Common stock$0.605▲ 21.00%Market cap $29.43MP/E —$0.41$8.27
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ABVC ABVC BioPharma Inc. Common Stock | $27.09M | — | $0.918 | ▼ 1.61% | $0.7069$3.07 |
| KYNB Kyntra Bio Inc. Common Stock | $28.26M | 0.12 | $4.85 | ▼ 9.51% | $5.34$11.65 |
| RMTI Rockwell Medical Inc. Common Stock | $28.26M | — | $7.43 | ▼ 6.89% | $4.89$12.9 |
| GRCE Grace Therapeutics Inc. Common Stock | $28.44M | — | $1.89 | ▼ 3.08% | $1.79$5.18 |
| MIRA MIRA Pharmaceuticals Inc. Common Stock | $28.50M | — | $0.632 | ▼ 3.95% | $0.6$2.45 |
| AYTU Aytu BioPharma Inc. Common Stock | $25.01M | — | $2.04 | ▲ 1.49% | $1.8$3.07 |
| ACTU Actuate Therapeutics Inc. Common stock | $29.43M | — | $0.605 | ▲ 21.00% | $0.41$8.27 |
P/E shows — for peers not currently carrying a live signal of their own.
Institutional Ownership
March 31, 2026
- Total shares held
- 729.9K
- Total value held
- $708.1K
- Institutional holders
- 13
- Unknown221.2K
- Unknown190.6K
- Unknown95.1K
- Unknown72.8K
- Unknown56.4K
- Unknown32.1K
- Unknown21.0K
- Unknown12.2K
- Unknown10.7K
- Unknown10.5K
See the full, filterable feed with live charts on the MarketWall dashboard.